Literature DB >> 7317558

Estimation of the proportional hazard in two-treatment-group clinical trials.

L Bernstein, J Anderson, M C Pike.   

Abstract

Two easily-computed approximate methods of obtaining an estimate of the ratio of the hazard rates for two treatments in survival analysis are compared, by simulation, with the partial maximum likelihood (CML) estimator which assumes the Cox model with no covariates. The two methods studied are the Mantel-Haenszel estimator, and the O/E method which employs the ratio of the 'relative death rates' for the two treatments. Uncensored and censored cases are examined for both continuous and tied data with the assumption of either an underlying exponential distribution or a Weibull distribution with shape parameter 2. The O/E method is biased but, within the range of values of the ratio of the hazard rates of interest in clinical trials, it is more efficient in terms of mean square error than either CML or the Mantel-Haenszel method for all but the largest trials. The Mantel-Haenszel method is minimally biased, gives answers very close to those obtained using CML, and may be used to provide satisfactory approximate confidence intervals.

Entities:  

Mesh:

Year:  1981        PMID: 7317558

Source DB:  PubMed          Journal:  Biometrics        ISSN: 0006-341X            Impact factor:   2.571


  7 in total

1.  Analysis of the role of hematopoietic stem-cell transplantation in infants with acute lymphoblastic leukemia in first remission and MLL gene rearrangements: a report from the Children's Oncology Group.

Authors:  ZoAnn E Dreyer; Patricia A Dinndorf; Bruce Camitta; Harland Sather; Mei K La; Meenakshi Devidas; Joanne M Hilden; Nyla A Heerema; Jean E Sanders; Ron McGlennen; Cheryl L Willman; Andrew J Carroll; Fred Behm; Franklin O Smith; William G Woods; Kamar Godder; Gregory H Reaman
Journal:  J Clin Oncol       Date:  2010-12-06       Impact factor: 44.544

2.  Endothelial Stromal PD-L1 (Programmed Death Ligand 1) Modulates CD8+ T-Cell Infiltration After Heart Transplantation.

Authors:  William Bracamonte-Baran; Nisha A Gilotra; Taejoon Won; Katrina M Rodriguez; Monica V Talor; Byoung C Oh; Jan Griffin; Ilan Wittstein; Kavita Sharma; John Skinner; Roger A Johns; Stuart D Russell; Robert A Anders; Qingfeng Zhu; Marc K Halushka; Gerald Brandacher; Daniela Čiháková
Journal:  Circ Heart Fail       Date:  2021-09-24       Impact factor: 10.447

3.  Consumption of Grapes Modulates Gene Expression, Reduces Non-Alcoholic Fatty Liver Disease, and Extends Longevity in Female C57BL/6J Mice Provided with a High-Fat Western-Pattern Diet.

Authors:  Asim Dave; Eun-Jung Park; Avinash Kumar; Falguni Parande; Diren Beyoğlu; Jeffrey R Idle; John M Pezzuto
Journal:  Foods       Date:  2022-07-05

4.  Analysis of prognostic factors of acute lymphoblastic leukemia in infants: report on CCG 1953 from the Children's Oncology Group.

Authors:  Joanne M Hilden; Patricia A Dinndorf; Sharon O Meerbaum; Harland Sather; Doojduen Villaluna; Nyla A Heerema; Ron McGlennen; Franklin O Smith; William G Woods; Wanda L Salzer; Helen S Johnstone; Zoann Dreyer; Gregory H Reaman
Journal:  Blood       Date:  2006-03-23       Impact factor: 22.113

5.  A preliminary trial of a novel form of active immunotherapy in squamous cell carcinoma of the lung.

Authors:  P J Lachmann; R M Grant; L S Freedman; K Sikora; N M Bleehen
Journal:  Br J Cancer       Date:  1985-03       Impact factor: 7.640

6.  The corticotropin-releasing factor-like diuretic hormone 44 (DH44) and kinin neuropeptides modulate desiccation and starvation tolerance in Drosophila melanogaster.

Authors:  Elizabeth Cannell; Anthony J Dornan; Kenneth A Halberg; Selim Terhzaz; Julian A T Dow; Shireen-A Davies
Journal:  Peptides       Date:  2016-02-17       Impact factor: 3.750

7.  A multivariate analysis of genomic polymorphisms: prediction of clinical outcome to 5-FU/oxaliplatin combination chemotherapy in refractory colorectal cancer.

Authors:  J Stoehlmacher; D J Park; W Zhang; D Yang; S Groshen; S Zahedy; H-J Lenz
Journal:  Br J Cancer       Date:  2004-07-19       Impact factor: 7.640

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.